Univest
Univest
  • Markets

CCL Products vs Caplin Point vs Gandhar Oil Refinery: Which Stock Should You Track

  • October 1, 2026
  • Posted by: Kunal Singla
  • Category: Market
No Comments
CCL Products vs Caplin Point vs Gandhar Oil Refinery: Which Stock Should You Track

CCL Products India PE 31.47, mkt cap Rs 13,609 crore. Caplin Point Laboratories PE 30.37, mkt cap Rs 20,590 crore. Gandhar Oil Refinery India PE 8.60, mkt cap Rs 2,726 crore.

Quick Answer

CCL Products India vs Caplin Point Laboratories vs Gandhar Oil Refinery India is a side-by-side comparison of three companies from the Pharma and Consumer Exports space. On this comparison, CCL Products India carries a market capitalisation of about Rs 13,609 crore against Rs 20,590 crore for Caplin Point Laboratories and Rs 2,726 crore for Gandhar Oil Refinery India, with return on equity of 16.55%, 17.88% and 10.01% respectively. Each company’s numbers are presented here without a declared better pick, since the right stock depends on an investor’s own criteria.

CCL Products India vs Caplin Point Laboratories vs Gandhar Oil Refinery India starts with the core numbers most investors compare within the Pharma and Consumer Exports segment: market capitalisation, valuation multiples, profitability and dividend yield. Figures below are sourced as of September 2026 and will shift with daily price moves.

All three names sit in the Pharma and Consumer Exports bucket, which makes them a natural set to place side by side rather than a random trio of unrelated businesses.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • CCL Products India, Caplin Point Laboratories and Gandhar Oil Refinery India: Company Overview
  • CCL Products India vs Caplin Point Laboratories vs Gandhar Oil Refinery India: Valuation and Profitability Snapshot
  • CCL Products India vs Caplin Point Laboratories vs Gandhar Oil Refinery India: Latest Quarterly Results
  • What Should Investors Look at Beyond These Numbers?
  • Conclusion
  • FAQs on CCL Products India vs Caplin Point Laboratories vs Gandhar Oil Refinery India
    • What is the market cap difference between CCL Products India, Caplin Point Laboratories and Gandhar Oil Refinery India?
    • Which of the three has the highest PE ratio?
    • Which of the three has the highest ROE?
    • Which of these three stocks pays the highest dividend yield?
    • What is the debt to equity ratio for CCL Products India, Caplin Point Laboratories and Gandhar Oil Refinery India?
    • Which of the three trades at the highest price to book value?
    • Is one of CCL Products India, Caplin Point Laboratories or Gandhar Oil Refinery India better than the others?

CCL Products India, Caplin Point Laboratories and Gandhar Oil Refinery India: Company Overview

CCL Products India is a listed Indian company in the Pharma and Consumer Exports space, tracked here on book value, return ratios and valuation alongside its peers in this comparison.

Caplin Point Laboratories is a listed Indian company in the Pharma and Consumer Exports space, tracked here on book value, return ratios and valuation alongside its peers in this comparison.

Gandhar Oil Refinery India is a listed Indian company in the Pharma and Consumer Exports space, tracked here on book value, return ratios and valuation alongside its peers in this comparison.

CCL Products India vs Caplin Point Laboratories vs Gandhar Oil Refinery India: Valuation and Profitability Snapshot

Metric CCL Products India Caplin Point Laboratories Gandhar Oil Refinery India
Market Cap (approx.) Rs 13,609 crore Rs 20,590 crore Rs 2,726 crore
PE Ratio (TTM) 31.47 30.37 8.60
PB Ratio 5.80 6.11 2.02
Return on Equity (ROE) 16.55% 17.88% 10.01%
EPS (TTM, Rs) 32.39 89.20 32.39
Dividend Yield 0.56% 0.30% 0.27%
Debt to Equity 0.56 0.00 0.23
Book Value per Share (Rs) 175.59 443.33 138.17

Check the Univest Screener for Live Data

On valuation, CCL Products India trades at a PE of 31.47 and a PB of 5.80, Caplin Point Laboratories at a PE of 30.37 and a PB of 6.11, while Gandhar Oil Refinery India trades at a PE of 8.60 and a PB of 2.02. On return on equity, the three post 16.55%, 17.88% and 10.01% respectively, and on dividend yield they stand at 0.56%, 0.30% and 0.27%.

CCL Products India vs Caplin Point Laboratories vs Gandhar Oil Refinery India: Latest Quarterly Results

Company Latest Quarter Revenue Latest Quarter Net Profit YoY Change (Revenue) QoQ Change (Revenue)
CCL Products India Rs 1,203.59 crore Rs 116.87 crore +13.8% -1.9%
Caplin Point Laboratories Rs 643.91 crore Rs 179.09 crore +20.7% +2.4%
Gandhar Oil Refinery India Rs 1,734.95 crore Rs 205.89 crore +91.6% +58.1%

Quarterly figures above are the most recent reported quarter for each company (Q1 FY27, quarter ended June 2026), compared with the year-ago and preceding quarter.

Download the Univest iOS App or Univest Android App to track CCL Products India, Caplin Point Laboratories and Gandhar Oil Refinery India live prices.

What Should Investors Look at Beyond These Numbers?

Beyond the metrics above, investors comparing these three pharma and consumer exports names should track quarter-on-quarter revenue and margin trends, management commentary on demand and cost drivers, and any sector-specific regulatory developments, since a single-quarter snapshot can shift quickly.

Conclusion

CCL Products India vs Caplin Point Laboratories vs Gandhar Oil Refinery India highlights how differently three companies in the same pharma and consumer exports segment can score across valuation, profitability and dividend metrics, even when operating in a similar space. This comparison does not declare a winner; investors should weigh these figures against their own research and risk appetite. Please read the disclaimer below before making any investment decision.

Disclaimer: Data and figures in this article are sourced from publicly available information as of September 2026 and may not reflect real-time prices. Please verify all data independently before making any investment decision. This comparison does not recommend or endorse any single stock over another; investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

FAQs on CCL Products India vs Caplin Point Laboratories vs Gandhar Oil Refinery India

What is the market cap difference between CCL Products India, Caplin Point Laboratories and Gandhar Oil Refinery India?

Ans. As of September 2026, CCL Products India has a market cap of approximately Rs 13,609 crore, Caplin Point Laboratories is at approximately Rs 20,590 crore, and Gandhar Oil Refinery India is at approximately Rs 2,726 crore.

Which of the three has the highest PE ratio?

Ans. Among CCL Products India, Caplin Point Laboratories and Gandhar Oil Refinery India, the PE ratios stand at 31.47, 30.37 and 8.60 respectively as of September 2026.

Which of the three has the highest ROE?

Ans. CCL Products India, Caplin Point Laboratories and Gandhar Oil Refinery India post ROE of 16.55%, 17.88% and 10.01% respectively as of September 2026.

Which of these three stocks pays the highest dividend yield?

Ans. CCL Products India, Caplin Point Laboratories and Gandhar Oil Refinery India carry dividend yields of 0.56%, 0.30% and 0.27% respectively.

What is the debt to equity ratio for CCL Products India, Caplin Point Laboratories and Gandhar Oil Refinery India?

Ans. CCL Products India carries a debt to equity of 0.56, Caplin Point Laboratories of 0.00, and Gandhar Oil Refinery India of 0.23.

Which of the three trades at the highest price to book value?

Ans. CCL Products India, Caplin Point Laboratories and Gandhar Oil Refinery India trade at price to book ratios of 5.80, 6.11 and 2.02 respectively.

Is one of CCL Products India, Caplin Point Laboratories or Gandhar Oil Refinery India better than the others?

Ans. This comparison does not declare one stock better than another; each company scores differently across valuation, profitability and dividend metrics, and the right fit depends on an individual investor’s own criteria and research.



pharma and consumer exports Stock Market
Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply